TAK – Takeda Pharmaceutical Co Ltd

武田制药 (Takeda Pharmaceutical Co Ltd) 是一家在日本注册成立的上市公司。公司及其附属公司为全球主要制药集团,从事医药产品,非处方药及准药物消费品及其他保健产品的研究,开发,制造及营销。Takeda的主要医药产品包括以下治疗领域的药物:胃肠病学,肿瘤学和神经科学。

中文介绍: https://xueqiu.com/S/TAK

Takeda Pharmaceutical is Japan’s largest pharmaceutical company, with revenue of JPY 3.3 trillion in 2019. The company’s five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 70% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

英文介绍: https://www.morningstar.com/stocks/xnys/tak/quote

主题测试文章,只做测试使用。发布者:star,转转请注明出处:http://wallstreetgm.com/tak-takeda-pharmaceutical-co-ltd/

发表评论

邮箱地址不会被公开。 必填项已用*标注

评论列表(1条)